Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

2.0K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

63
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
63
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Development of Immunocompetence01:22

Development of Immunocompetence

473
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
473
Teratogenicity01:07

Teratogenicity

2.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study.

Lancet (London, England)·2026
Same author

Exploring supplemental immunization strategies to reach zero-dose children in low- and middle-income countries: a scoping review.

Therapeutic advances in vaccines and immunotherapy·2026
Same author

National genomic profiling of Plasmodium falciparum antimalarial resistance in Zambian children participating in the 2018 malaria indicator survey.

Scientific reports·2026
Same author

Individual and population level uncertainty interact to determine the performance of outbreak surveillance systems.

PLoS computational biology·2026
Same author

Evaluation of serum antibodies as correlates of protection against norovirus infection and disease.

The Journal of infectious diseases·2026
Same author

Timing of antiretroviral treatment initiation and seropositivity to measles virus among children living with HIV in rural Zambia.

medRxiv : the preprint server for health sciences·2026
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: Sep 28, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K

Rubella.

Amy K Winter1, William J Moss2

  • 1Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens GA, USA.

Lancet (London, England)
|April 3, 2022
PubMed
Summary
This summary is machine-generated.

Rubella virus causes a mild illness but can lead to congenital rubella syndrome in infants if contracted during pregnancy. Vaccination is key to preventing rubella and its severe complications.

More Related Videos

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
08:58

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

Published on: April 30, 2019

9.0K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.2K

Related Experiment Videos

Last Updated: Sep 28, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K
Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
08:58

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

Published on: April 30, 2019

9.0K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.2K

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Rubella is an acute viral illness characterized by fever and rash.
  • Primary rubella virus infection during early pregnancy can cause Congenital Rubella Syndrome (CRS), posing significant public health challenges.
  • The World Health Organization (WHO) estimates around 100,000 CRS cases annually.

Purpose of the Study:

  • To provide a comprehensive overview of rubella virus infection.
  • To highlight the risks and consequences of Congenital Rubella Syndrome.
  • To emphasize the importance of rubella vaccination for disease prevention and eradication.

Main Methods:

  • Review of existing literature on rubella virus epidemiology, clinical manifestations, and prevention strategies.
  • Analysis of data on global rubella vaccine coverage.
  • Synthesis of information on the public health impact of rubella and CRS.

Main Results:

  • Rubella virus is transmitted via respiratory droplets and direct contact, with 25-50% of infected individuals being asymptomatic.
  • Clinical rubella typically presents as a mild, self-limiting illness with fever, rash, and lymphadenopathy, but can lead to complications like arthritis and encephalitis.
  • Congenital Rubella Syndrome (CRS) manifests with severe conditions including cataracts, hearing impairment, heart defects, and microcephaly.

Conclusions:

  • Rubella and CRS can be effectively prevented through rubella-containing vaccines, often combined with the measles vaccine.
  • Despite challenges, global rubella eradication is an achievable public health goal.
  • Increased global rubella vaccine coverage is crucial for preventing devastating congenital outcomes.